Home  |  Contact

Cellosaurus FU-266 (CVCL_J235)

[Text version]

Cell line name FU-266
Synonyms FU 266
Accession CVCL_J235
Resource Identification Initiative To cite this cell line use: FU-266 (RRID:CVCL_J235)
Comments Characteristics: Produces IgE lambda.
Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
Derived from sampling site: Peripheral blood.
Sequence variations Heterozygous for BRAF p.Lys601Asn (c.1803A>T) (from parent cell line).
Heterozygous for MSH6 p.Gly141Asp (c.422G>A) (from parent cell line).
Homozygous for TP53 p.Ala161Thr (c.481G>A) (ClinVar=VCV000161518) (from parent cell line).
Homozygous for TRAF3 p.Lys550Leufs*3 (c.1648_1649insT) (from parent cell line).
Disease Plasma cell myeloma (NCIt: C3242)
Multiple myeloma (ORDO: Orphanet_29073)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0566 (U266B1)
Children:
CVCL_J236 (FU-266 clone E1)
Sex of cell Male
Age at sampling 53Y
Category Cancer cell line
Publications

PubMed=6316357; DOI=10.1073/pnas.80.23.7308
Teng N.N.H., Lam K.S., Calvo Riera F., Kaplan H.S.
Construction and testing of mouse -- human heteromyelomas for human monoclonal antibody production.
Proc. Natl. Acad. Sci. U.S.A. 80:7308-7312(1983)

Patent=US4574116
Kaplan H.S., Teng N.N.H., Lam K.S., Calvo-Riera F.
Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes.
Patent number US4574116, 04-Mar-1986

Cross-references
Other Wikidata; Q54835231
Entry history
Entry creation11-Feb-2013
Last entry update02-Jul-2020
Version number12